# Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer

> **NCT03548285** · NA · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Glottic Carcinoma

## Interventions

- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT03548285
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-15
- **Primary completion:** 2023-04-25
- **Final completion:** 2024-04-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03548285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03548285, "Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03548285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*